Pulmuone Corporate (KRX:017810)
9,710.00
+650.00 (7.17%)
Jun 9, 2026, 11:30 AM KST
Pulmuone Corporate Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 3,437,051 | 3,380,189 | 3,213,697 | 2,993,468 | 2,838,304 | 2,518,896 |
Other Revenue | 0 | - | -0 | - | - | -0 |
| 3,437,051 | 3,380,189 | 3,213,697 | 2,993,468 | 2,838,304 | 2,518,896 | |
Revenue Growth (YoY) | 6.15% | 5.18% | 7.36% | 5.47% | 12.68% | 8.99% |
Cost of Revenue | 2,592,922 | 2,548,565 | 2,399,222 | 2,234,427 | 2,137,885 | 1,862,661 |
Gross Profit | 844,128 | 831,625 | 814,475 | 759,041 | 700,419 | 656,235 |
Selling, General & Admin | 681,980 | 676,414 | 663,105 | 634,863 | 611,262 | 556,782 |
Research & Development | 30,999 | 30,671 | 29,790 | 29,646 | 27,630 | 28,289 |
Amortization of Goodwill & Intangibles | 6,844 | 6,895 | 7,193 | 8,327 | 8,214 | 7,919 |
Operating Expenses | 743,198 | 738,451 | 722,646 | 697,060 | 674,087 | 617,721 |
Operating Income | 100,930 | 93,173 | 91,829 | 61,981 | 26,332 | 38,514 |
Interest Expense | -62,045 | -62,856 | -66,049 | -56,168 | -39,170 | -29,052 |
Interest & Investment Income | 3,868 | 4,025 | 3,956 | 3,417 | 3,119 | 2,772 |
Currency Exchange Gain (Loss) | 3,236 | -1,415 | 10,061 | 109.76 | 3,168 | 2,028 |
Other Non Operating Income (Expenses) | -1,594 | -1,473 | 8,572 | 12,679 | -13,786 | 11,246 |
EBT Excluding Unusual Items | 44,396 | 31,455 | 48,370 | 22,020 | -20,337 | 25,508 |
Gain (Loss) on Sale of Investments | 1,796 | 1,608 | 2,179 | 2,983 | 2,782 | -2,887 |
Gain (Loss) on Sale of Assets | 1,500 | 1,478 | -497.35 | -1,745 | 702.46 | 2,582 |
Asset Writedown | -3,733 | -3,733 | -9,081 | -8,946 | -1,560 | -11,694 |
Pretax Income | 43,958 | 30,807 | 40,970 | 14,312 | -18,413 | 13,509 |
Income Tax Expense | 19,883 | 15,647 | 6,584 | 954.08 | 18,554 | 13,205 |
Earnings From Continuing Operations | 24,075 | 15,160 | 34,387 | 13,358 | -36,967 | 304.16 |
Minority Interest in Earnings | 2,285 | 2,935 | 1,016 | 6,158 | 18,365 | 13,053 |
Net Income | 26,360 | 18,095 | 35,403 | 19,516 | -18,602 | 13,357 |
Preferred Dividends & Other Adjustments | 14,988 | 14,988 | 11,950 | 10,151 | 11,355 | 8,032 |
Net Income to Common | 11,372 | 3,107 | 23,453 | 9,365 | -29,957 | 5,326 |
Net Income Growth | -15.63% | -48.89% | 81.41% | - | - | -17.95% |
Shares Outstanding (Basic) | 67 | 37 | 37 | 37 | 37 | 37 |
Shares Outstanding (Diluted) | 68 | 37 | 46 | 46 | 37 | 37 |
Shares Change (YoY) | 71.57% | -19.22% | 0.39% | 24.22% | -0.12% | -10.84% |
EPS (Basic) | 169.43 | 84.24 | 636.79 | 254.69 | -814.69 | 144.67 |
EPS (Diluted) | 166.83 | 83.00 | 545.97 | 216.23 | -815.00 | 144.67 |
EPS Growth | -71.97% | -84.80% | 152.50% | - | - | -63.31% |
Free Cash Flow | 34,723 | 14,276 | 79,373 | 70,924 | -49,313 | -98,629 |
Free Cash Flow Per Share | 510.85 | 385.43 | 1730.98 | 1552.74 | -1341.08 | -2679.13 |
Gross Margin | 24.56% | 24.60% | 25.34% | 25.36% | 24.68% | 26.05% |
Operating Margin | 2.94% | 2.76% | 2.86% | 2.07% | 0.93% | 1.53% |
Profit Margin | 0.33% | 0.09% | 0.73% | 0.31% | -1.05% | 0.21% |
Free Cash Flow Margin | 1.01% | 0.42% | 2.47% | 2.37% | -1.74% | -3.92% |
EBITDA | 273,375 | 265,080 | 252,620 | 209,958 | 164,372 | 166,917 |
EBITDA Margin | 7.95% | 7.84% | 7.86% | 7.01% | 5.79% | 6.63% |
D&A For EBITDA | 172,445 | 171,907 | 160,791 | 147,977 | 138,040 | 128,403 |
EBIT | 100,930 | 93,173 | 91,829 | 61,981 | 26,332 | 38,514 |
EBIT Margin | 2.94% | 2.76% | 2.86% | 2.07% | 0.93% | 1.53% |
Effective Tax Rate | 45.23% | 50.79% | 16.07% | 6.67% | - | 97.75% |
Advertising Expenses | - | 50,961 | 56,637 | 58,400 | 56,970 | 51,898 |